Mar 21, 2022 EBMT 2022 Annual Meeting - Presidential Symposium Abstract Presentation - Post-transplant Cyclophosphamide vs Antithymocyte Globulin in Patients with ALL treated in CR1 with Allo-HCT from Matched Unrelated Donors
Mar 21, 2022 EBMT 2022 Annual Meeting - Presidential Symposium Abstract Presentation - Engineering T-Cells to prevent GvHD and Leukemia Relapse following Allogeneic SCT
Mar 20, 2022 EBMT 2022 Annual Meeting - Keynote Lecture - allo-HCT in Paediatric Acute Lymphoblastic Leukaemia, state of art
Mar 17, 2022 EBMT works together with edenceHealth, Studio Hyperdrive and De Cronos Groep to develop a new data platform